[{"Assets_0_Q2_USD":189389000.0,"CommonStockSharesOutstanding_0_Q2_shares":23472574.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-80621000.0,"NetIncomeLoss_1_Q2_USD":-39603000.0,"NetIncomeLoss_2_Q2_USD":-82821000.0,"StockholdersEquity_0_Q2_USD":-185493000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]